CHARLOTTE, North Carolina, June 15, 2026 (GLOBE NEWSWIRE) -- Magnera Corporation (NYSE: MAGN) today announced the sale of its Caerphilly, UK operations to Polyart Group, a Prudentia Capital holding. Following a strategic portfolio review of its manuf

HOUSTON, June 15, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) announced positive operational updates offshore Gabon regarding the ongoing drilling program, including impressive initial well results o

Live since October 2025 and already counting hundreds of thousands of users, IFANN is being positioned as a serious contender for the long-promised "everything app" - and Rock Digital LLC is doubling down with the launch of a Creator Rewards Program

RUEIL-MALMAISON, France and TAIPEI, Taiwan, June 15, 2026 (GLOBE NEWSWIRE) -- Schneider Electric, a global energy technology leader, today announced a strategic collaboration with Hon Hai Technology Group (Foxconn), the world’s largest electronics ma

Dublin, Ireland and Heppenheim, Germany--(Newsfile Corp. - June 15, 2026) - Cosmo N.V. (SIX: COPN) (FSE: C43) (“Cosmo”) is pleased to announce the launch of its innovative acne cream Winlevi® (clascoterone 1% cream) in Austria and Germany by its comm

Taipei, Taiwan--(Newsfile Corp. - June 15, 2026) - At Computex 2026, AMZFAST unveiled its most ambitious display lineup to date, expanding beyond traditional gaming monitors into smart entertainment, premium OLED gaming, creator-focused displays, and

Shenzhen, China--(Newsfile Corp. - June 14, 2026) - As parents increasingly seek healthier alternatives to screen-based entertainment, Haivivi has officially launched BubblePal, an innovative AI-powered companion toy designed to transform ordinary pl

Poster presentations from ongoing clinical trials of two core assets, olverembatinib and lisaftoclax, highlight global innovation capabilities in hematologic malignancies ROCKVILLE, Md. and SUZHOU, China, June 14, 2026 (GLOBE NEWSWIRE) -- Ascentage P

ZW191 demonstrates compelling anti-tumor activity in platinum-resistant ovarian cancer patients regardless of FRα expression levelConfirmed objective response rate (cORR) of 78.6% in FRα-positive (≥75% at PS2+) platinum-resistant ovarian cancer patie

Data show investigational atumelnant drove sustained androgen reductions while enabling lowering of glucocorticoid supplementation to physiologically normal levels in adults with classic CAH New results from the Phase 1b/2a ACTH-dependent Cushing’s s